Posted at: 11/20/2009 2:36 PM
By:
Print Story
Email to a Friend
Pfizer’s Geodon gets expanded FDA approval
(AP) NEW YORK - Pfizer Inc. said Friday the Food and Drug Administration approved Geodon as a part of a combination maintenance treatment for bipolar disorder in adults.
The new approval covers use of Geodon as an adjunct to lithium or valproate.
The drug is already approved as a treatment for schizophrenia and bipolar disorder.
Shares of Pfizer rose 20 cents to $18.31 in afternoon trading.
(Copyright 2009 by The Associated Press. All Rights Reserved.)
